The 59th Annual Meeting of the Japanese Society of Child Neurology

Session information

Oral Presentation

neuromuscular disease

[O6] Oral Presentation
muscle disease 1

Thu. Jun 15, 2017 11:20 AM - 12:20 PM Room No.7 (10F Conference Room 1004-1005)

Chair:Hirofumi Komaki(Department of Clinical Research Promotion, National Center of Neurology and Psychiatry, Tokyo, Japan), Hiroyuki Awano(Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan)

Hiroyuki Awano1, Masaaki Matsumoto1, Masashi Nagai1, Taku Shirakawa2, Teruaki Takasaki2, Nobuhiro Maruyama3, Yoichi Nabeshima4, Masafumi Matsuo2, Kazumoto Iijima1 (1.Kobe Graduate School of Medicine, Kobe Japan, 2.Department of Physical Therapy, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan, 3.Diagnostic & Research Reagents Division, Immuno-Biological Laboratories Co., Ltd. Fujioka, Japan, 4.Laboratory of Molecular Life Science, Foundation for Biomedical Research and Innovation, Kobe, Japan)

Tomoko Lee1, Hideki Shimomura1, Hiroyuki Awano2, Kazumoto Iijima2, Hiroshi Ogi3, Kyoko Ito3, Masafumi Matsuo4, Yasuhiro Takeshima1 (1.Department of Pediatrics, Hyogo College of Medicine, Nishinomiya, Japan, 2.Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan, 3.Department of Pathology and Applied Neurobiology Graduate School of Medical Science Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Department of Medical Rehabilitation, Kobegakuin University, Kobe, Japan)

Eri Takeshita1, Yasuyuki Iwata2, Hiroyuki Yajima2, Hisateru Tachimori3, Naohiro Kato3, Hirofumi Komaki1,4, Masayuki Sasaki1, Outcome Measures Study Group5 (1.Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan, 2.Department of Physical Rehabilitation Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan, 3.Department of Mental Health and Policy, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 4.Department of Clinical Research Promotion, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan, 5.Muscular Dystrophy Clinical Trial Network Study group for outcome measures)

Toshio Saito1, Katsuhisa Ogata2, Satoshi Kuru3, Tsuyoshi Matsumura1, Toshiaki Takahashi4, Michio Kobayashi5, Hiroto Takada6, Takashi Mikata7, Hajime Arahata8, Michinori Funato9, Takayasu Fukudome9,10 (1.Division of Child Neurology, Department of Neurology, National Hospital Orga nization Toneyama National Hospital, Toyonaka, Japan, 2.Department of Neurology, National Hospital Organization Higashisaitama Hospital, Hasuda, Saitama, Japan, 3.Department of Neurology, National Hospital Organization National Suzuka Hospital, Suzuka, Mie, Japan, 4.Department of Neurology, National Hospital Organization Sendai-Nishitaga National Hospital, Sendai, Miyagi, Japan, 5.Department of Neurology, National Hospital Organization National Akita Hospital, Yurihonjo, Akita, Japan, 6.Department of Neurology, National Hospital Organization National Aomori Hospital, Aomori, Japan, 7.Department of Neurology, National Hospital Organization National Shimoshizu Hospital, Yotsukaido, Chiba, Japan, 8.Department of Neurology, National Hospital Organization Omuta Hospital, Omura, Japan, 9.Department of Pediatrics, National Hospital Organization Nagara medical Center, Nagara, Japan, 10.Department of Neurology, National Hospital Organization Nagasaki Kawatana Medical Center, Nagasaki, Japan)

Ayako Hattori1, Ayako Hattori1, Yuji Nakamura1, Daisuke Ieda1, Ikumi Hori1, Yutaka Negishi1, Yuko Motohashi2, Hirofumi Komaki2, Satoshi Kuru3, Shinji Saitoh1 (1.Nagoya City University, Graduate school of Medical Sciences, Department of Pediatrics and Neonatology, Aichi, Japan, 2.Department of Child Neurology , National Center Hospital, National Center of Neurology and Psychiatry (NCNP) , Tokyo , Japan, 3.National Hospital Organization Suzuka National Hospital, Department of Neurology, Mie, Japan)